Welcome to our dedicated page for Mannatech news (Ticker: MTEX), a resource for investors and traders seeking the latest updates and insights on Mannatech stock.
The Mannatech, Incorporated (NASDAQ: MTEX) news page on Stock Titan aggregates the company’s latest announcements, earnings releases, and corporate updates. Mannatech describes itself as a global health and wellness company focused on nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through a worldwide network of independent associates and preferred customers.
Investors and followers of MTEX can use this news feed to review quarterly and annual financial results, including net sales, regional performance across the Americas, Asia/Pacific, and EMEA, gross profit trends, commission and selling expense levels, and income from operations. Mannatech also regularly discusses non-GAAP Constant dollar measures that adjust for foreign currency translation, giving additional context on underlying business trends.
Beyond earnings, Mannatech’s news includes governance and leadership developments, such as board appointments, executive promotions or resignations, and outcomes of the annual shareholders’ meeting, including director elections and advisory votes on executive compensation. The company also issues releases highlighting marketing initiatives and brand stories, such as documentaries and testimonials related to its glycan-based nutritional products.
Because Mannatech operates in multiple international markets and uses a direct selling model, its news often addresses topics like associate and preferred customer counts, recruiting trends, economic conditions in key regions, and the impact of trade policies and tariffs on its cost structure. Bookmark this page to quickly access new MTEX press releases, financial commentary, and other official communications as they are reported.
Mannatech, Incorporated (NASDAQ: MTEX) reported second-quarter 2022 net sales of $35.0 million, down 17.7% from $42.5 million in Q2 2021, impacted by foreign exchange losses. Operating income fell to $0.9 million compared to $2.0 million the previous year. Net income decreased to $0.7 million, or $0.34 per diluted share, significantly lower than $2.1 million, or $0.99 per diluted share, in Q2 2021. Year-to-date sales also dropped 16.7% year-on-year, illustrating continuing operational challenges and supply chain constraints.
Mannatech, a global health and wellness company, announced the successful passage of all shareholder proposals during its annual meeting on June 14, 2022. Notable outcomes included the election of J. Stanley Fredrick and Tyler Rameson as Class II Directors, with 66.5% of shares represented. Additionally, shareholders ratified BDO USA, LLP as independent auditors for the fiscal year ending December 31, 2022, and approved the compensation for Mannatech's named executive officers. The company emphasizes its commitment to transforming lives through high-quality nutritional products.
Mannatech, a global health and wellness company, announced a cash dividend of $0.20 per share, payable on June 29, 2022, to shareholders recorded by June 15, 2022. This move reflects the company's commitment to rewarding shareholders and promoting long-term investment in its common stock. President and CEO, Alfredo Bala, emphasized Mannatech's dedication to delivering shareholder value. The company operates globally in 25 markets and is focused on health, weight management, fitness, and skin care products.
Mannatech, Incorporated (NASDAQ: MTEX) reported first quarter 2022 financial results with net sales of $32.4 million, a decline of 15.5% from $38.3 million in Q1 2021. On a constant dollar basis, net sales decreased by 11.5%. Supply chain issues led to deferred revenue of $0.9 million in Asia Pacific, affecting sales. Operating income fell to less than $0.1 million compared to $2.8 million in Q1 2021, while net income was $0.1 million, or $0.06 per diluted share. The number of fulfilled orders decreased by 6%, and recruitment of associates dropped by 5.1%.
Mannatech, Incorporated (NASDAQ: MTEX) reported Q4 2021 net sales of $39.5 million, up 0.8% from Q4 2020. Operating income improved to $1.0 million compared to an operating loss of $11.0 thousand in Q4 2020. Net income reached $2.6 million ($1.25 per diluted share), a significant increase from $0.7 million ($0.34 per diluted share) in the prior year. Gross profit margin improved to 77.5%. Year-end net sales increased 5.5% to $160.3 million, with net income for 2021 at $9.8 million ($4.71 per diluted share). The company returned $4.3 million in dividends and repurchased $5.1 million in stock.
Mannatech, Incorporated (NASDAQ: MTEX) has announced a cash dividend of $0.20 per share for its common stock. This dividend will be paid on March 30, 2022, to shareholders recorded by the close of business on March 16, 2022. The decision reflects the company's commitment to rewarding its investors and sustaining long-term interest in its stock. CEO Alfredo Bala emphasized the company's dedication to delivering shareholder value.
Mannatech declared a cash dividend of $1.70 per share, payable on December 29, 2021, to shareholders of record on December 15, 2021. This dividend includes a quarterly portion of $0.20 and a special dividend of $1.50, highlighting the company's commitment to shareholder value. CEO Alfredo Bala emphasized the intent to reward and encourage long-term investment in Mannatech. With over 25 years in business and a presence in 25 markets, the company continues focusing on health and wellness products.
Mannatech reported third quarter 2021 net sales of $39.4 million, a 3.9% increase from $38.0 million in Q3 2020. Income from operations rose to $3.3 million, compared to $1.4 million in the prior year. Net income reached $2.9 million, or $1.44 per diluted share, up from $1.6 million, or $0.76 per diluted share in Q3 2020. Year-to-date sales were $120.3 million, a 7.2% increase year-over-year. Recruitment of independent associates declined by 1.4% to 25,036 in Q3 2021.
Mannatech, Incorporated (NASDAQ: MTEX) has approved a share repurchase program to buy back up to $1.0 million of its outstanding common stock. The repurchase will occur in the open market or through negotiated transactions at management's discretion, influenced by market conditions. This initiative begins on September 21, 2021, and concludes either on September 21, 2022, or upon reaching the purchase limit. Mannatech plans to finance the repurchases using available cash, aiming to enhance shareholder value.
Mannatech, Incorporated (NASDAQ: MTEX) has declared a cash dividend of $0.20 per share, payable on September 29, 2021. This dividend is aimed at rewarding shareholders and promoting long-term investment. Shareholders on record as of September 15, 2021 will receive this dividend. CEO Alfredo 'Al' Bala emphasized the company's commitment to delivering value to its investors. Mannatech operates globally in the health and wellness sector, offering products through independent associates in over 25 markets.
FAQ
What is the current stock price of Mannatech (MTEX)?
What is the market cap of Mannatech (MTEX)?
